The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Selliah, N.
Right arrow Articles by Finkel, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selliah, N.
Right arrow Articles by Finkel, T. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference
The Journal of Immunology, 1998, 160: 5697-5701.
Copyright © 1998 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness1

Nithianandan Selliah* and Terri H. Finkel2,*,{dagger}

* Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206; {dagger} Departments of Immunology, Pediatrics, and Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, Denver, CO 80262

In early HIV disease, immunodeficiency is characterized by the inability of CD4+ T cells to produce a critical cytokine, IL-2, and to express the receptor for IL-2 (IL-2R) in response to antigenic or mitogenic stimulation. The shared common {gamma}-chain ({gamma}c) of IL-2R and its associated Janus kinase, JAK3, are indispensable for normal T cell function. Here, we show that the inhibition of IL-2R expression and proliferation induced by ligation of CD4 by HIV envelope glycoprotein, gp120, is correlated with inhibition of expression and activation of JAK3. Stimulation through the {gamma}c-related cytokine receptors restores JAK3 expression and activation and rescues CD4-mediated T cell unresponsiveness. Collectively, these data argue that inhibition of JAK3 expression and activation may, in part, explain the T cell dysfunction seen in early HIV disease. In addition, rescue from gp120-mediated T cell unresponsiveness by activation of JAK3 suggests a novel therapeutic approach for enhancing immune function in HIV disease.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. F. Zheng, G. J. Jones, M. Shi, J. C. D. Wiseman, K. J. Marr, B. M. Berenger, S. M. Huston, M. J. Gill, A. M. Krensky, P. Kubes, et al.
Late Expression of Granulysin by Microbicidal CD4+ T Cells Requires PI3K- and STAT5-Dependent Expression of IL-2R{beta} That Is Defective in HIV-Infected Patients
J. Immunol., June 1, 2008; 180(11): 7221 - 7229.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Fernando, H. Hu, H. Ni, J. A. Hoxie, and D. Weissman
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
Blood, March 15, 2007; 109(6): 2538 - 2544.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
G. Borkow and Z. Bentwich
Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy
Clin. Microbiol. Rev., October 1, 2004; 17(4): 1012 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. J. Kohler, D. L. Tuttle, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow
Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages
J. Leukoc. Biol., March 1, 2003; 73(3): 407 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Esser, J. W. Bess Jr., K. Suryanarayana, E. Chertova, D. Marti, M. Carrington, L. O. Arthur, and J. D. Lifson
Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1
J. Virol., February 1, 2001; 75(3): 1152 - 1164.
[Abstract] [Full Text]


Home page
BloodHome page
C. Bovolenta, L. Camorali, A. L. Lorini, S. Ghezzi, E. Vicenzi, A. Lazzarin, and G. Poli
Constitutive Activation of STATs Upon In Vivo Human Immunodeficiency Virus Infection
Blood, December 15, 1999; 94(12): 4202 - 4209.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Neben, M. Heidbreder, J. Muller, A. Marxer, H. Petry, A. Didier, A. Schimpl, T. Hunig, and T. Kerkau
Impaired thymopoietic potential of immature CD3–CD4+CD8– T cell precursors from SIV-infected rhesus monkeys
Int. Immunol., September 1, 1999; 11(9): 1509 - 1518.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Mathew, I. Kurane, S. Green, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, F. A. Ennis, and A. L. Rothman
Impaired T Cell Proliferation in Acute Dengue Infection
J. Immunol., May 1, 1999; 162(9): 5609 - 5615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.